Business

China Business

Are Chinese biotechs what the doctor ordered as Big Pharma faces ‘patent cliff’?

US drug makers are racing to plug looming ‘patent cliff’ revenue gaps – and increasingly they are turning to China biotechs.

China’s Sugon launches AI infrastructure to rival platforms from Nvidia, Huawei

China Vanke’s managers have no plans to sell shares as firm fights for survival

Vanke, responding to queries from investors, says top managers have not notified it about their intentions so far.

videocam
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
OPINION
Hiba Malik

Opinion | How China is cementing its central role as the architect of green tech

Anthony Rowley
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
MULTIMEDIA
Video

Pony.ai set to further open China’s autonomous-driving frontier

Pony.ai
07:39
Advertisement
Advertisement
Advertisement
TRENDING TOPICS
Hong Kong stock exchange
Advertisement
Advertisement
Advertisement
MOST POPULAR
1

UOB marks 90th anniversary in Singapore by honouring communities, colleagues and customers

In partnership with:
UOB